Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0016
A Phase III Trial of CHOP vs. CHOP + Rituximab vs. CHOP + Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) For Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas
Research Committee(s)
Lymphoma
Activated
03-01-2001
Closed
10-02-2008
Closed
Phase
Accrual
56%
Published
SWOG Clinical Trial Number
S0031
Evaluation of ZD 1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
02-15-2001
Closed
10-15-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9915
A Phase II Study of PN401, 5-FU, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach.
Research Committee(s)
Gastrointestinal Cancer
Activated
02-15-2001
Closed
09-01-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0033
"Phase III Randomized, Intergroup Trial Assessing the Clinical Activity of STI-571 at Two Dose Levels in Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) Expressing the KIT Receptor Tyrosine Kinase (CD117)"
Research Committee(s)
Sarcoma
Activated
12-15-2000
Closed
09-01-2001
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0003
Randomized Phase III Trial of Carboplatin and Paclitaxel plus Tirapazamine versus Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer - Cisplatin, Paclitaxel, Tirapazamine vs. Cisplatin, Paclitaxel - Specimen submission per S9925
Research Committee(s)
Lung Cancer
Activated
11-15-2000
Closed
11-15-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0007
Evaluation of 3 Hour Infusion of Paclitaxel Plus Cisplatin and 5-Fluorouracil in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Research Committee(s)
Head and Neck Cancer
Activated
11-01-2000
Closed
05-15-2003
Closed
Phase
Accrual
2%
Published
SWOG Clinical Trial Number
S0019
A Randomized Phase III Trial of ICE Chemotherapy With or Without Rituximab for the Treatment of Relapsed or Refractory CD20 Expressing Agressive B-Cell Non-Hodgkin's Lymphomas in Patients Not Suitable for High Dose Therapy and PBSCT.
Research Committee(s)
Lymphoma
Activated
10-15-2000
Closed
12-15-2001
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
S0004
A Phase I Study of Tirapazamine/Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-2000
Closed
04-01-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9912
Phase II Evaluation of Intravenous Paclitaxel, Intraperitoneal Cisplatin, Intravenous Liposomal Doxorubicin and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Research Committee(s)
Gynecologic Cancer
Activated
10-01-2000
Closed
08-15-2005
Closed
Phase
Accrual
36%
Published
SWOG Clinical Trial Number
S0013
Evaluation of In Vitro Assays as Predictors of Clinical Outcome in Patients With Locally Advanced (Stage IIB-IVA)Cervical Carcinoma, Biologic
Research Committee(s)
Gynecologic Cancer
Activated
09-15-2000
Closed
11-15-2003
Closed
Phase
SWOG Clinical Trial Number
S9925
Lung Cancer Specimen Repository Protocol, Ancillary
Research Committee(s)
Lung Cancer
Activated
09-01-2000
Closed
03-15-2010
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
S0008
Phase III Trial of High Dose Interferon Alpha-2b versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients with High Risk Melanoma
Research Committee(s)
Melanoma
Activated
08-01-2000
Closed
11-15-2007
Closed
Phase
Accrual
48%
SWOG Clinical Trial Number
S0010
A Phase II Trial of 506U78 (IND 52611) in Patients With Relapsed or Refractory Non T-Cell Acute Lymphoblastic Leukemia (ALL)
Research Committee(s)
Leukemia
Activated
07-15-2000
Closed
03-15-2004
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S9920
A Phase III Randomized Study Comparing Busulfan – Total Body Irradiation Versus Cyclophosphamide – Total Body Irradiation Preparative Regimen in Patients with Advanced Myelodysplastic Syndrome (MDS) or MDS – Related Acute Myeloid Leukemia (AML) Undergoing HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation, (A BMT Study)
Research Committee(s)
Leukemia
Activated
06-15-2000
Closed
10-15-2001
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
S9927
Randomized Trial of Post-Mastectomy Radiotherapy in Stage II Breast Cancer in Women With One to Three Positive Axillary Nodes, Phase III
Research Committee(s)
Breast Cancer
Activated
06-15-2000
Closed
06-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9923
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Colorectal Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
08-01-2001
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9924
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Pancreas Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
06-01-2001
Closed
Phase
Accrual
3%
SWOG Clinical Trial Number
S9901
A Randomized Phase III Trial Comparing Early High Dose Chemotherapy and an Autologous Stem Cell Transplant to Conventional Dose ABVD Chemotherapy for Patients with Advanced Stage Poor Prognosis Hodgkin’s Disease as Defined by the International Prognostic Factors Project on Advanced Hodgkin’s Disease, Intergroup
Research Committee(s)
Lymphoma
Activated
04-15-2000
Closed
11-01-2001
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
S9922
A Phase III Trial of Dexamethasone, Cyclophosphamide, Etoposide, Cisplatin (DCEP) and G-CSF With or Without Thalidomide (NSC #66847) as Salvage Therapy for Patients with Refractory Multiple Myeloma
Research Committee(s)
Myeloma
Activated
04-15-2000
Closed
11-01-2001
Closed
Phase
Accrual
56%
SWOG Clinical Trial Number
S9926
Phase II Study of Temozolomide in Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)
Research Committee(s)
Sarcoma
Activated
04-15-2000
Closed
09-01-2003